Received Sep 17, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MNQ | MENINGOCOCCAL CONJUGATE (MENVEO) | NOVARTIS VACCINES AND DIAGNOSTICS | UNK | UNK | — |
75-year-old asplenic patient was administered Menveo; This non-serious case was reported by a pharmacist via sales rep and described the occurrence of inappropriate age at vaccine administration in a elderly male patient who received Men ACWY-CRM NVS (Menveo) for prophylaxis. On an unknown date, the patient received Menveo (unknown deltoid). On an unknown date, an unknown time after receiving Menveo, the patient experienced inappropriate age at vaccine administration (Verbatim: 75-year-old asplenic patient was administered Menveo). The outcome of the inappropriate age at vaccine administration was not applicable. Additional Information: GSK Receipt Date: 22-AUG-2025 The pharmacist reported that asplenic patient was administered Menveo off-label. The patient received dose of Menveo vaccine at an inappropriate age, which led to inappropriate age at vaccine administration.